Hibiscus: Research
Overview
This page provides a curated overview of selected peer‑reviewed scientific studies examining Hibiscus sabdariffa, a botanical commonly prepared from dried hibiscus calyces as a tea or extract. The goal of this page is to provide transparent access to commonly cited research in the scientific literature. The summaries below describe findings reported in published studies. They are presented for educational purposes as part of a clinician‑led review of the scientific literature.
Important Context for Readers
Scientific studies examine outcomes in defined populations under specific research conditions. Results reported in individual studies may not apply to all individuals, and findings should not be interpreted as guaranteed outcomes. This page summarizes selected research examining cardiovascular, blood pressure, metabolic, lipid, and vascular biomarkers studied in relation to hibiscus. It is not intended to provide medical advice, diagnosis, or treatment recommendations. This page is provided for educational purposes and does not include product recommendations or affiliate links.
Summary of Evidence
Across human clinical studies and meta-analyses, hibiscus has been studied primarily for its potential associations with changes in blood pressure biomarkers, especially systolic and diastolic blood pressure. Some studies have also examined lipid markers, glucose-related markers, body composition, vascular function, and oxidative stress.
While results vary across study populations and trial designs, multiple randomized studies and meta-analyses have reported favorable changes in blood pressure under study conditions. Many studies are short-term, involve modest sample sizes, use different preparations, and focus on biomarkers rather than long-term clinical outcomes.
Key Areas of Research
Blood Pressure and Cardiovascular Markers
Evidence strength: Moderate
Randomized trials and meta-analyses have examined hibiscus tea, infusions, and standardized extracts in adults with elevated blood pressure or related cardiometabolic risk factors.
1) Haji Faraji M, Haji Tarkhani AH. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmacol. 1999.
PMID: 10404421
DOI: https://doi.org/10.1016/S0378-8741(98)00157-3
Population: Adults with essential hypertension.
Design: Randomized clinical study evaluating sour tea prepared from Hibiscus sabdariffa.
Key findings:
• Reductions in systolic and diastolic blood pressure were reported during the intervention period
• Blood pressure values increased after discontinuation in the studied population
• Findings contributed to early clinical interest in hibiscus as a cardiovascular botanical
• Results should be interpreted in the context of a short study duration and defined hypertensive population
2) Herrera-Arellano A, Flores-Romero S, Chávez-Soto MA, et al. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine. 2004.
PMID: 15330492
DOI: https://doi.org/10.1016/j.phymed.2004.04.001
Population: Adults with mild to moderate hypertension.
Design: Controlled randomized clinical trial comparing a standardized hibiscus preparation with captopril.
Key findings:
• Systolic blood pressure decreased from approximately 139 to 124 mmHg in the hibiscus group under study conditions
• Diastolic blood pressure decreased from approximately 91 to 80 mmHg in the hibiscus group
• The hibiscus preparation was reported as well tolerated in the study population
• Findings support further investigation of standardized hibiscus preparations for blood pressure-related biomarkers
3) Herrera-Arellano A, Miranda-Sánchez J, Avila-Castro P, et al. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension: a randomized, double-blind, lisinopril-controlled clinical trial. Planta Med. 2007.
PMID: 17315307
DOI: https://doi.org/10.1055/s-2006-957065
Population: Adults with hypertension.
Design: Randomized, double-blind, lisinopril-controlled clinical trial evaluating a standardized hibiscus herbal medicinal product.
Key findings:
• Reductions in systolic and diastolic blood pressure were reported in the hibiscus group
• Lisinopril produced greater blood pressure reductions than hibiscus in this active-comparator study
• Hibiscus was reported as generally well tolerated
• Findings are useful for context but should not be interpreted as evidence that hibiscus replaces antihypertensive therapy
4) Mozaffari-Khosravi H, Jalali-Khanabadi BA, Afkhami-Ardekani M, et al. The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes. J Hum Hypertens. 2009.
PMID: 18685605
DOI: https://doi.org/10.1038/jhh.2008.100
Population: Adults with type 2 diabetes and mild hypertension.
Design: Randomized clinical study comparing sour tea with black tea.
Key findings:
• Reductions in systolic blood pressure were reported in the sour tea group
• Pulse pressure decreased in the sour tea group under study conditions
• Findings suggest hibiscus tea may influence blood pressure biomarkers in selected cardiometabolic populations
• Results should be interpreted within the context of short-term tea consumption and a specific diabetic population
5) McKay DL, Chen CY, Saltzman E, et al. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr. 2010.
PMID: 20018807
DOI: https://doi.org/10.3945/jn.109.115097
Population: Adults with prehypertension or mild hypertension not taking blood pressure-lowering medications.
Design: Randomized, double-blind, placebo-controlled trial evaluating 3 servings/day of brewed hibiscus tea for 6 weeks.
Key findings:
• Systolic blood pressure decreased by approximately 7.2 mmHg in the hibiscus tea group compared with approximately 1.3 mmHg in the placebo group
• Diastolic blood pressure decreased by approximately 3.1 mmHg in the hibiscus group, though the between-group difference was not statistically significant
• Participants with higher baseline systolic blood pressure showed greater response
• Findings support an association between daily hibiscus tea intake and changes in blood pressure biomarkers under study conditions
6) Nwachukwu DC, Aneke E, Nwachukwu NZ, et al. Effect of Hibiscus sabdariffa on blood pressure and electrolyte profile of mild to moderate hypertensive Nigerians: a comparative study with hydrochlorothiazide. Niger J Clin Pract. 2015.
PMID: 26289514
DOI: https://doi.org/10.4103/1119-3077.163278
Population: Adults with mild to moderate hypertension.
Design: Comparative clinical study evaluating aqueous hibiscus extract and hydrochlorothiazide.
Key findings:
• Blood pressure reductions were reported in the hibiscus group
• Electrolyte-related outcomes were also evaluated
• Findings provide additional clinical context for hibiscus and blood pressure-related biomarkers
• Results should be interpreted cautiously because study design and comparator choice differ from placebo-controlled trials
Several pooled analyses have evaluated hibiscus across randomized trials, with the strongest consistency observed for blood pressure markers.
7) Hopkins AL, Lamm MG, Funk JL, et al. Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies. Fitoterapia. 2013.
PMID: 23333908
DOI: https://doi.org/10.1016/j.fitote.2013.01.003
Population: Review of animal and human studies evaluating hibiscus and cardiometabolic outcomes.
Design: Comprehensive review of preclinical and clinical literature.
Key findings:
• Human studies most consistently examined blood pressure outcomes
• Lipid-related findings were more variable across the literature
• The review emphasized the need for higher-quality human studies with better-defined preparations and dosing
• This paper is useful as a widely cited overview of the early hibiscus cardiovascular literature
8) Boushehri SN, Karimbeiki R, Ghasempour S, et al. The efficacy of sour tea (Hibiscus sabdariffa L.) on selected cardiovascular disease risk factors: a systematic review and meta-analysis. Phytother Res. 2020.
PMID: 31943427
DOI: https://doi.org/10.1002/ptr.6541
Population: Adults across clinical trials evaluating cardiovascular risk markers.
Design: Systematic review and meta-analysis.
Key findings:
• Pooled analyses reported reductions in systolic and diastolic blood pressure
• Some favorable changes in glycemic markers were reported across selected analyses
• Lipid findings were less consistent across included studies
• Heterogeneity was noted across populations, study designs, hibiscus preparations, and intervention durations
9) Ellis LR, Zulfiqar S, Holmes M, et al. A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers. Nutr Rev. 2022.
PMID: 34927694
DOI: https://doi.org/10.1093/nutrit/nuab104
Population: Adults across randomized and controlled studies evaluating blood pressure and cardiometabolic markers.
Design: Systematic review and meta-analysis.
Key findings:
• Hibiscus was associated with reductions in systolic and diastolic blood pressure compared with placebo or no-intervention controls
• Effects were most apparent in studies involving mild to moderate hypertension
• Hibiscus was not consistently superior to active comparators such as antihypertensive drugs
• Findings support further research into dose, preparation type, and treatment duration
Vascular Function and Postprandial Markers
Evidence strength: Moderate
Some human studies have examined vascular function and short-term cardiometabolic responses after hibiscus intake.
10) Abubakar SM, Ukeyima MT, Spencer JPE, et al. Acute effects of Hibiscus sabdariffa calyces on postprandial blood pressure, vascular function, blood lipids, biomarkers of insulin resistance and inflammation in humans. Nutrients. 2019.
PMID: 30764582
DOI: https://doi.org/10.3390/nu11020341
Population: Adults evaluated under postprandial study conditions.
Design: Acute human intervention study examining vascular and cardiometabolic biomarkers after hibiscus calyx extract intake.
Key findings:
• Postprandial vascular function was evaluated after hibiscus calyx extract consumption
• The study examined blood pressure, vascular function, lipids, insulin-related markers, and inflammatory biomarkers
• Findings suggested potential effects on vascular function, though longer-term studies are needed
• Results should be interpreted as short-term biomarker findings rather than long-term clinical outcomes
Educational Notice
These summaries are provided for educational purposes to review published scientific literature and should not be interpreted as medical advice, diagnosis, or treatment recommendations. Readers should consult qualified healthcare professionals for personal medical decisions.
FDA Disclaimer
These statements have not been evaluated by the U.S. Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.
FTC Affiliate Disclosure
Some pages on this website may contain affiliate links to products. If readers choose to purchase through those links, the site may receive a commission. Affiliate relationships do not influence the selection or discussion of scientific studies summarized on this reference page.